PTENFRES
Neutroplast

External Audit 2026: Neutroplast Maintains Its Certifications with Zero Non-Conformities

Neutroplast has successfully completed its 2026 external surveillance audit, maintaining ISO 9001, ISO 14001 and ISO 15378 certifications with zero non-conformities, reinforcing its commitment to quality, traceability and sustainability.

Auditoria Externa 2026: Neutroplast mantém certificações sem não conformidades

Neutroplast has successfully completed its 2026 surveillance audit, maintaining its ISO 9001, ISO 14001 and ISO 15378 certifications with zero non-conformities.

In industries where quality, traceability and regulatory compliance are essential, independent external audits provide an important validation of internal processes and an organisation's ability to consistently meet demanding standards.

Quality and Compliance as an Ongoing Commitment

Maintaining these certifications reflects the daily commitment of Neutroplast's teams to consistent manufacturing processes, strict quality control and continuous improvement.

The audit covered our Quality Management, Environmental Management and Good Manufacturing Practice systems for primary pharmaceutical packaging, confirming compliance with the requirements of the applicable international standards.

For our customers, compliance is more than meeting regulatory requirements. It means operational predictability, reliability and confidence throughout every stage of the supply chain.

Sustainability as an Integral Part of Our Business

The audit also recognised Neutroplast's ongoing commitment to sustainability and circular economy initiatives.

Over recent years, the company has participated in several innovation and sustainability projects while continuing to invest in environmental certifications, waste reduction initiatives and the development of more responsible packaging solutions.

For Neutroplast, sustainability is not a trend—it is a long-term strategic commitment.

Continuous Improvement Never Stops

Although the audit concluded without any non-conformities, it also identified opportunities for further improvement in areas such as training, knowledge management, risk assessment and internal process optimisation.

These recommendations provide valuable guidance to further strengthen our management systems and support continuous organisational development.

At Neutroplast, operational excellence is not achieved through a single successful audit, but through a culture of continuous improvement, learning and adaptation.

A Trusted European Partner for Regulated Industries

For pharmaceutical, cosmetic, nutraceutical and medical device manufacturers, selecting a packaging supplier involves much more than choosing a product.

Complete documentation, full traceability, reliable supply, controlled manufacturing processes and regulatory compliance are essential to reducing risk and ensuring operational predictability.

Maintaining our certifications and achieving these audit results further reinforces Neutroplast's commitment to remaining a trusted European partner for companies operating in highly regulated and technically demanding markets.

More news

See all
Company

Pedro Redol appointed CEO of Neutroplast

Pedro Redol takes on the executive leadership of Neutroplast as CEO, strengthening the company's focus on innovation, sustainability and international growth.

Company

Neutroplast at Maghreb Pharma 2026

Neutroplast will be present at Maghreb Pharma 2026 in Algiers, showcasing packaging solutions for pharmaceutical, nutraceutical and cosmetic industries.